Abstract
There is concern that statin use may exacerbate nonalcoholic fatty liver disease (NAFLD). We aimed to assess the association of statin use with NALFD and severity of liver fibrosis among NAFLD individuals. We evaluated 6,385 cross-sectional healthy Brazilian subjects (43 ± 10 years, 79% males) without clinical coronary heart disease between November 2008 and July 2010. NAFLD was diagnosed by ultrasound. Severity of liver fibrosis was predicted by fatty liver index and FIB-4. NAFLD prevalence was 36% (n = 2310). Overall 552 (9%) individuals were using statins of whom 49% had NAFLD. Statin users were more likely to be men, older age, and have higher burden of risk factors (p <0.05). In age gender adjusted analysis the odds ratio for NAFLD with statin use was 0.87 (0.61-1.25, p = 0.46) in the presence of metabolic syndrome and 1.08 (0.88-1.32, p = 0.56) in its absence. On further adjustment for metabolic risk factors, LDL and smoking the results remained unchanged (OR: 0.89, 95% CI: 0.65-1.32, p = 0.56 and 0.90 (0.69-1.18, p = 0.46). There was no significant association between statin use and fatty liver index in a subanalysis of NAFLD individuals (71 ± 18 vs. 69 ± 23, p = 0.18). Although FIB-4 was mildly elevated with statin use ...Continue Reading
References
Nov 1, 1993·Circulation·D PerloffB Z Morgenstern
Jan 22, 2000·Annals of Internal Medicine·S BellentaniC Tiribelli
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Apr 19, 2002·The New England Journal of Medicine·Paul Angulo
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giulio MarchesiniMario Rizzetto
May 12, 2004·Atherosclerosis·Loukianos S RallidisAikaterini S Parasi
Mar 25, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naga Chalasani
Jun 1, 2005·The American Journal of Medicine·Evguenia C CharlesJohn A Merenich
Aug 20, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·L A Adams, P Angulo
Sep 15, 2005·Circulation·Scott M GrundyUNKNOWN National Heart, Lung, and Blood Institute
Sep 20, 2005·Atherosclerosis·Stavros AntonopoulosGregory Giannoulis
Dec 16, 2005·The American Journal of the Medical Sciences·Brent A Neuschwander-Tetri
Apr 4, 2006·The American Journal of Cardiology·David E CohenUNKNOWN National Lipid Association Statin Safety Task Force Liver Expert Panel
May 16, 2006·Alimentary Pharmacology & Therapeutics·E Gómez-DomínguezR Moreno-Otero
Jun 17, 2006·Minerva cardioangiologica·G Marchesini, M Babini
Jul 25, 2009·Current Treatment Options in Cardiovascular Medicine·Sweta Tandra, Raj Vuppalanchi
Jun 10, 2011·Digestive Diseases and Sciences·W NseirN Assy
Sep 29, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hideyuki HyogoSusumu Tazuma
Jan 10, 2012·BMC Gastroenterology·Yoshio SumidaUNKNOWN Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
Mar 13, 2012·European Heart Journal·Lokpal S BhatiaChristopher D Byrne
Mar 16, 2012·Digestive Diseases and Sciences·William NseirMurad Ghali
May 19, 2012·Current Opinion in Cardiology·Lokpal S BhatiaChristopher D Byrne
Oct 31, 2012·Circulation·Ravi V Shah, Allison B Goldfine
Jan 19, 2013·Current Atherosclerosis Reports·William Nseir, Mahmud Mahamid
Jan 25, 2013·Neurology·Manuel CappellariDanilo Toni
Citations
Jul 6, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Z Reiner
May 2, 2014·Current Atherosclerosis Reports·Zeljko Reiner
Feb 27, 2018·Journal of Viral Hepatitis·J Y ChenA A Butt
Oct 17, 2019·Frontiers in Medicine·Abdulrahman Ismaiel, Dan L Dumitraşcu
Jul 29, 2017·Current Gastroenterology Reports·Jose Ignacio VargasJuan Pablo Arab